4. Intracranial Pressure ICP
• Normal values < 10 - 15mmHg for adults and
older children
• 3 to 7 mm Hg for young children
• 1.5 to 6 mm Hg for term infants
• ICP can be subatmospheric in newborns
• ICP values > 20 - 25 mm Hg require treatment
• Sustained ICP > 40 mm Hg indicate severe, life-threatening
intracranial hypertension.
NIMHANS
5. Cerebral Perfusion Pressure (CPP)
• CPP = MAP - ICP
• Normal cerebral blood flow (CBF) with a CPP
ranging from 50 to 150 mm Hg
• CPP < 50 mm Hg CBF falls passively with CPP
• After injury the ability of the brain to pressure
autoregulate may be absent or impaired and,
even with a normal CPP, CBF can passively
follow changes in CPP
NIMHANS
7. Secondary raised ICP
• 30% of patients
• 3 to 10 days after trauma
• Delayed hematoma
• Hypoxia
• Hypotension
• Vasospasm
• Hypoventilation
• Hyponatremia
NIMHANS
8. ICP WAVES
• Lundberg A waves: Plateau waves
– Amplitude > 50 mm Hg lasting 5 to 20 min.
– Accompanied by increase in MAP
• Lundberg B waves: Pressure pulses
– Amplitude 50 mm Hg and lasting 30 sec. to 2 min.
NIMHANS
• Lundberg C waves:
– Amplitude 20 mm Hg and frequency of 4 – 8/ min.
13. Alcohol
• 24% regular consumers
• 15% under influence of alcohol
NIMHANS
• More severe injuries
• Multiple intracranial hematomas
• Delirium and withdrawal
• Liver dysfunction
14. Concussion
• Transient loss of brain function due to blow on head
• Orientation, Immediate memory, Concentration
• Grade 1: __ Transient Confusion
__ No Loss of Consciousness
__ Concussion Symptoms < 15 min.
• Grade 2: __ Transient Confusion
__ No Loss of Consciousness
__ Concussion Symptoms > 15 min.
• Grade 3: __ Any Loss of Consciousness, Brief or Prolonged
NIMHANS
15. Unconsciousness
NIMHANS
• Concussion
• At time of impact
– Worsening
– Improving
• Delayed
• Lucid interval
• Amnesia
16. Seizures
• Generalized tonic clonic or focal
• Status epilepticus in 10 – 15%
• Postictal unconsciousness
NIMHANS
• Immediate
– No significance
• Early
– Severe injury
18. Examination
• A – Airway Wounds
• B – Breathing ENT bleeding
• C – Circulation CSF leak
• D – Disability
• E – Exposure
• F – Foley/ family
• G – Gastric tube
NIMHANS
36. MRI
• After clinical stabilization
• If CT scan is normal and patient is uncosncious
• 25 days after injury for prognostication
• Limited use only for research
• T1, T2, FLAIR and T2*
NIMHANS
38. Monitoring
NIMHANS
Hourly
• Pulse rate < 60 bpm
• BP < 90 mm Hg
• GCS > 2 score deterioration
• Pupils Asymmetry
• Limb movement Paucity
39. Treatment
• Head of bed elevation
• Normal blood pressure
NIMHANS
• Normal oxygenation
• Normal temperature
• Normal blood glucose
40. Indications for ICP monitoring
GCS: 3–8 (after resuscitation)
1. Abnormal admission head CT scan
2. Normal admission head CT scan plus two or
more of the following
a. Age > 40 yrs.
b. Motor posturing
c. Systolic blood pressure < 90 mm Hg
NIMHANS
41. Complications of ICP monitoring
• Infection: 5% to 14%
– Antibiotic-coated catheters has been shown to
reduce the risk for infection from 9.4% to 1.3%.
• Hemorrhage: 1.4%
• Malfunction, obstruction, and malposition
NIMHANS
42. Goals of ICP treatment
1. Maintain ICP at less than 20 to 25 mm Hg.
2. Maintain CPP at greater than 60 mm Hg by
maintaining adequate MAP.
3. Avoid factors that aggravate or precipitate
elevated ICP.
NIMHANS
44. Mannitol
NIMHANS
• Available as 20%
• Max. dose 5 ml/ kg
• BP should be normal
• Decorticate or decerebrate posturing
• Rapid deterioration of GCS
45. Hypertonic saline (HS)
• 3% to 23.4% HS as effective as mannitol
• Advantage over mannitol
– Hypovolemic and Hypotensive patients
NIMHANS
• Adverse effects
– Hematologic
• bleeding secondary to decreased platelet aggregation and
prolonged coagulation time
– Electrolyte abnormalities
• Hypokalemia and hyperchloremic acidosis
Hyponatremia should be excluded before administering
hypertonic saline, to reduce the risk for central
pontine myelinolysis
46. Barbiturates
NIMHANS
• Pentobarbital
– Loading dose 10 mg/kg
– 5 mg/kg every hour for 3 doses
– Maintenance 1 to 2 mg/kg/h
• Titrated to a serum level of 30 to 50 mg/mL or
until EEG shows a burst suppression pattern
• Barbiturate coma in patients with refractory
intracranial hypertension increases twofold
greater chance of controlling the ICP
47. Barbiturates
NIMHANS
• Mechanism:
– Coupled reduction in CBF and CMRO2, with an immediate
effect on ICP
– Retention of CO2 reactivity by brain
• Complications:
– Hypotension 58%
– Hypokalemia 82%
– Respiratory 76%
– Infections 55%
– Hepatic 87%
– Renal dysfunction 47%
48. Hypothermia
• Cerebral metabolism reduced by 5-7% for
each oC reduction
– Decreased glucose & O2 consumption
• Prevents cell injury leading to apoptosis
– Inhibition of caspase activation
– Prevents mitochondrial dysfunction
– Decreased excitatory neurotransmitters
– Modification of intracellular ion concentration
– Modification of intracellular acidosis
NIMHANS
50. Hypothermia
• 13 studies involving 1321 patients in last 15 years
– All reported a reduction in ICP
– Most observed improved neurological outcome especially
in patients with low GCS (4-7) on admission
– Results however not significant
NIMHANS
• Adverse effects
– Hypotensive episodes and bradycardia more common
– Low magnesium
– Insulin resistance
51. Decompressive Craniectomy (DECRA)
• Less time with raised ICP
• Fewer interventions for increased ICP
• Fewer days in ICU
• Worse scores on the GOS
• Greater risk of unfavorable outcome
• Rates of death at 6 months similar
NIMHANS
52. Antibiotics
• Not routinely required
• For contaminated depressed fracture
• Endotracheal intubation
NIMHANS
• Cefotaxime 1 gm tid
54. Anticonvulsants
NIMHANS
• Phenytoin
– Loading 18 mg/ kg iv in 100 ml NS over 30 min
– Maintenance 5 mg/ kg/ day
• 10 – 14 days for prophylaxis
• Continue as case of epilepsy in early PTS
55. Pharmacological Neuroprotection
• Pre-clinical and clinical data are disconnected
• Need adequate pre-clinical TBI models
• Virtually no early phase trials in TBI
• Dosing
• Duration of treatment
• Time of treatment initiation
NIMHANS
56. Design Problems
• Weaknesses in study design
• Insufficient power/sample size
• Inadequate outcome measures or lack of
sensitivity of the outcomes measure
• Too small effect sizes
• Too variable population
NIMHANS
57. Facts
• No single measure can capture the
multidimensional nature of TBI outcome
• Combination of drugs are needed for the
treatment of TBI
NIMHANS
• Current Trials
– Progesterone (SYNAPSE)
– Citicoline (COBRIT)
– Erythropoetin
60. Surgery for EDH
NIMHANS
Surgery
Any GCS
• Volume > 30 cc
• Volume > 20 cc
– Basitemporal
– Posterior fossa
Conservative
• Volume <20 cc
• Thickness < 15 mm
• Midline shift< 5 mm
• GCS > 8
• No deficits
Craniotomy with hitch stitches
61. Surgery for acute SDH
NIMHANS
Any GCS
• Thickness > 10 mm
• Midline shift > 5 mm
Thickness < 10 mm
Midline shift < 5 mm
• GCS < 9
• Deteriorated by 2 GCS
• Pupillary asymetry
Craniotomy with or without
bone flap replacement and duraplasty
62. Surgery for cerebral contusions
NIMHANS
Volume > 50 cc
• Any GCS
Volume > 20 cc
• GCS 6 – 8
• Progressive deterioration
• Failure of medical treatment
• Midline shift > 5 mm
• Cisternal compression
Craniotomy with evacuation of lesion
Decompressive craniectomy and
bone flap placement in abdominal wall
63. Surgery for posterior fossa lesions
• Neurological dysfunction or deterioration
• Distortion or obliteration of IV ventricle
• Cisternal compression
• Hydrocephalus
Suboccipital craniectomy and evacuation
NIMHANS
64. Surgery for depressed fracture
NIMHANS
Surgery
• Compound (open)
• Thickness > cranium
Nonoperative
• No dural breach
• No significant hematoma
• < 1 cm
• No infection
• No cosmetic deformity
• No pneumocephalus
Elevation with debridement
Duraplasty
Antibiotics
65. Glasgow outcome scale (GOS)
GOS
Favorable Unfavorable
NIMHANS
Good
Recovery
Upper
Lower
Moderate
Disability
Severe
Disability
Vegetative
State
Death
Upper
Lower
Upper
Lower
68. Prevention
If treatment is duty then prevention is responsibility
Helmet
• Not compulsory for pillion riders
• 60% compliance
• <5% at time of injury
• 6 times increase in mortality without helmet
• Myths – baldness, headache, neck injury, decreased vision
NIMHANS
etc.
69. No head injury is so trivial
that it can be ignored
Nor so serious
that life can be despaired off
NIMHANS
Editor's Notes
Hyperemia owing to vasomotor paralysis or loss of autoregulation
Hypoventilation that leads to hypercarbia with subsequent cerebral vasodilation
Hydrocephalus resulting from obstruction of the CSF pathways or its absorption
Increased intrathoracic or intra-abdominal pressure as a result of mechanical ventilation, posturing, agitation, or Valsalva’s maneuvers
Lundberg C waves: amplitude 20 mm Hg and a frequency of 4 to 8 per minute; they are seen in the normal ICP waveform, but
high-amplitude C waves may be superimposed on plateau waves
Flow chart summarizing various pathophysiological events involved in cerebral ischemic and traumatic insults. Four phases of
injury are indicated that divide the spectrum of processes into immediate, acute, subacute, and ultimate outcome. As indicated, similar
pathomechanisms are considered to participate in the structural and functional abnormalities associated with cerebral ischemia and
trauma. Degrees of involvement as well as temporal profiles of these events are important in determining whether they play a dominant
role in cell death and injury. As in any type of injury, injury severity and the presence of secondary injury mechanisms impact on the
robustness of these pathological events. It should be emphasized that there are generally more similarities in terms of pathogenesis
between cerebral ischemia and trauma than there are differences.
J Cereb Blood Flow Metab, Vol. 24, No. 2, 2004
American Academy of Neurology guidelines
Different abnormal respiratory patterns are associated with pathologic lesions (shaded areas) at various levels
of the brain. Tracings by chest-abdomen pneumography, inspiration reads up. (A) Cheyne-Stokes respiration is seen with
metabolic encephalopathies and with lesions that impair forebrain or diencephalic function. (B) Central neurogenic
hyperventilation is most commonly seen in metabolic encephalopathies, but may rarely be seen in cases of high brainstem
tumors. (C) Apneusis, consisting of inspiratory pauses, may be seen in patients with bilateral pontine lesions. (D) Cluster
breathing and ataxic breathing are seen with lesions at the pontomedullary junction. (E) Apnea occurs when lesions encroach
on the ventral respiratory group in the ventrolateral medulla bilaterally. (From Saper, C. Brain stem modulation of
sensation, movement, and consciousness. Chapter 45 in: Kandel, ER, Schwartz, JH, Jessel, TM. Principles of Neural Science.
4th ed. McGraw-Hill, New York, 2000, pp. 871–909.
Motor responses to noxious stimulation in patients with acute cerebral dysfunction. Levels of associated
brain dysfunction are roughly indicated at left. Patients with forebrain or diencephalic lesions often have a hemiparesis
(note lack of motor response with left arm, externally rotated left foot, and left extensor plantar response), but can generally
make purposeful movements with the opposite side. Lesions involving the junction of the diencephalon and the midbrain
may show decorticate posturing, including flexion of the upper extremities and extension of the lower extremities. As
the lesion progresses into the midbrain, there is generally a shift to decerebrate posturing (C), in which there is extensor
posturing of both upper and lower extremities. (From Saper, C. Brain stem modulation of sensation, movement, and consciousness.
Chapter 45 in: Kandel, ER, Schwartz, JH, Jessel,
Ocular reflexes in unconscious patients. The left-hand side shows the responses to oculocephalic maneuvers (which should only be done after the possibility of cervical
spine injury has been eliminated). The right-hand side shows responses to caloric stimulation with cold or warm water (see text for explanation). Normal brainstem reflexes in a
patient with metabolic encephalopathy are illustrated in row (A). The patient shown in row (B) has a lesion of the right side of the pons (see Figure 2–8), causing a paralysis of gaze
to that side with either eye. Row (C) shows the result of a lesion involving the medial longitudinal fasciculus (MLF) bilaterally (bilateral internuclear ophthalmoplegia). Only
abducens responses with each eye persist. The patient in row (D) has a lesion involving both MLFs and the right abducens nucleus (one and a half syndrome). Only left eye
abduction is retained. Row (E) illustrates a patient with a midbrain infarction eliminating both the oculomotor and trochlear responses, leaving only bilateral abduction responses.
Note that the extraocular responses are identical to (C), in which there is a bilateral lesion of the MLF. However, pupillary light responses would be preserved in the latter case.
(From Saper, C. Brain stem modulation of sensation, movement, and consciousness. Chapter 45 in: Kandel, ER, Schwartz, JH, Jessel, TM. Principles of Neural Science. 4th ed.
McGraw-Hill, New York, 2000, pp. 871–909. By permission of McGraw-Hill.)
%; colonization of the device is more
common than clinical infection [25]. A study found no significant reduction
in infection rate in patients undergoing prophylactic change of monitors before
day 5, compared with those whose catheters were in place for 5 days or
more [26]. Factors that are not associated with infection are insertion of the
catheter in the neurologic ICU, previous catheter insertion, drainage of CSF,
and use of steroids. In a group of patients who had prolonged ventricular
drainage of 10 days or more, a nonlinear increase in daily infection rate
was observed over the initial 4 days but remained constant, despite prolonged
catheter use [27].
also creates an osmotic force to draw water from the interstitial space of
the brain parenchyma into the intravascular compartment in the presence
of an intact blood–brain barrier, reducing intracranial volume and ICP.
Mannitol is contraindicated
in hypovolemic patients because of the diuretic effects, whereas hypertonic
saline augments intravascular volume and may increase blood pressure, in
addition to decreasing ICP.
. Although routine use of barbiturates in unselected
patients has not been consistently effective in reducing morbidity or mortality
after severe head injury [63,64], a randomized multicenter trial showedthat instituting
Reilly PL and Bullock R. Head injury pathophysiology and management. (2nd Edition) , Hodder Arnold; London 2005; pp 444